Skip to main content

and
  1. Article

    Open Access

    The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma

    Treatment with PARP inhibitors (PARPi) is primarily effective against high-grade serous ovarian cancers (HGSOC) with BRCA1/2 mutations or other deficiencies in homologous recombination (HR) repair mechanisms. How...

    Francesco Morra, Francesco Merolla in Journal of Experimental & Clinical Cancer … (2022)